These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8764667)

  • 41. Anxiolytic effect of estradiol in the median raphe nucleus mediated by 5-HT1A receptors.
    Andrade TG; Nakamuta JS; Avanzi V; Graeff FG
    Behav Brain Res; 2005 Aug; 163(1):18-25. PubMed ID: 15951031
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors.
    Kumar JR; Rajkumar R; Lee LC; Dawe GS
    Neuropharmacology; 2016 Nov; 110(Pt A):1-14. PubMed ID: 27436722
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serotonin 5-HT
    Depoortère R; Bardin L; Varney MA; Newman-Tancredi A
    ACS Chem Neurosci; 2019 Jul; 10(7):3101-3107. PubMed ID: 30929419
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serotonin 2C receptors in the basolateral amygdala mediate the anxiogenic effect caused by serotonergic activation of the dorsal raphe dorsomedial subnucleus.
    Matthiesen M; Mendes LD; Spiacci A; Fortaleza EA; Corrêa FM; Zangrossi H
    J Psychopharmacol; 2020 Apr; 34(4):391-399. PubMed ID: 31637976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. S 15535, a novel benzodioxopiperazine ligand of serotonin (5-HT)1A receptors: II. Modulation of hippocampal serotonin release in relation to potential anxiolytic properties.
    Millan MJ; Hjorth S; Samanin R; Schreiber R; Jaffard R; De Ladonchamps B; Veiga S; Goument B; Peglion JL; Spedding M; Brocco M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):148-61. PubMed ID: 9223550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The mechanism by which the selective 5-HT1A receptor antagonist S-(-) UH 301 produces head-twitches in mice.
    Darmani NA; Reeves SL
    Pharmacol Biochem Behav; 1996 Sep; 55(1):1-10. PubMed ID: 8870031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.
    Millan MJ; Canton H; Gobert A; Lejeune F; Rivet JM; Bervoets K; Brocco M; Widdowson P; Mennini T; Audinot V
    J Pharmacol Exp Ther; 1994 Jan; 268(1):337-52. PubMed ID: 8301575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential responsiveness of the rat dorsal and median raphe 5-HT systems to 5-HT1 receptor agonists and p-chloroamphetamine.
    Blier P; Serrano A; Scatton B
    Synapse; 1990; 5(2):120-33. PubMed ID: 2137943
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Low doses of 8-OH-DPAT prevent the impairment of spatial learning caused by intrahippocampal scopolamine through 5-HT(1A) receptors in the dorsal raphe.
    Carli M; Balducci C; Samanin R
    Br J Pharmacol; 2000 Sep; 131(2):375-81. PubMed ID: 10991934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization of MP349, a novel 5-HT1A-receptor antagonist with anxiolytic-like activity, in mice and rats.
    Wesołowska A; Paluchowska MH; Gołembiowska K; Chojnacka-Wójcik E
    J Pharm Pharmacol; 2003 Apr; 55(4):533-43. PubMed ID: 12803776
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of 5-HT1A receptor agonists and NMDA receptor antagonists in the social interaction test and the elevated plus maze.
    Dunn RW; Corbett R; Fielding S
    Eur J Pharmacol; 1989 Oct; 169(1):1-10. PubMed ID: 2574684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intraventricular galanin modulates a 5-HT1A receptor-mediated behavioural response in the rat.
    Misane I; Razani H; Wang FH; Jansson A; Fuxe K; Ogren SO
    Eur J Neurosci; 1998 Apr; 10(4):1230-40. PubMed ID: 9749777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist.
    De Vry J; Schohe-Loop R; Heine HG; Greuel JM; Mauler F; Schmidt B; Sommermeyer H; Glaser T
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1082-94. PubMed ID: 9495870
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential effect of gepirone on presynaptic and postsynaptic serotonin receptors: single-cell recording studies.
    Blier P; de Montigny C
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):13S-20S. PubMed ID: 1973935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of serotonin 1A receptors in the median raphe nucleus on the behavioral consequences of forced swim stress.
    Almeida PV; Trovo MC; Tokumoto AM; Pereira AC; Padovan CM
    J Psychopharmacol; 2013 Dec; 27(12):1134-40. PubMed ID: 24162801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain.
    Casanovas JM; Lésourd M; Artigas F
    Br J Pharmacol; 1997 Oct; 122(4):733-41. PubMed ID: 9375971
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Full agonistic properties of BAY x 3702 on presynaptic and postsynaptic 5-HT1A receptors electrophysiological studies in the rat hippocampus and dorsal raphe.
    Dong J; de Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1239-47. PubMed ID: 9732384
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of 5-HT
    Hernandes PM; Batistela MF; Vilela-Costa HH; Sant'Ana AB; Kumpel VD; Tirapelle MC; Bom AOP; de Andrade TGCS; Zangrossi H
    Behav Brain Res; 2021 Jun; 408():113296. PubMed ID: 33862061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.